Glassman Wealth Services’s Bionano Genomics BNGO Stock Holding History

Glassman Wealth Services’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	–	–	1936
2022 Q3	–	Hold	0	–	–	–	1675
2022 Q2	–	Hold	0	–	–	–	1683
2022 Q1	–	Hold	0	–	–	–	1656
2021 Q4	–	Sell	-1	Closed	-$4K	–	1654
2021 Q3	$4K	Hold	1	–	–	﹤0.01%	1006
2021 Q2	$5K	Hold	1	–	–	﹤0.01%	900
2021 Q1	$5K	Buy	+1	New	+$5.64K	﹤0.01%	848

Other funds holding BNGO

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Glassman Wealth Services's BNGO Position: Q4 2022 in Review

Glassman Wealth Services held its Bionano Genomics (BNGO) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

Glassman Wealth Services first reported a position in BNGO in Q1 2021 and has held it in 3 quarters since. The position peaked at $5K in Q2 2021. 143 funds tracked by Wall St. Rank hold BNGO as of Q4 2022.

Glassman Wealth Services held 0 shares of Bionano Genomics worth $0 as of Q4 2022.
Glassman Wealth Services left its Bionano Genomics share count unchanged in Q4 2022.
Bionano Genomics made up ﹤0.01% of Glassman Wealth Services's portfolio in Q4 2022, its #1936 holding.
Glassman Wealth Services first reported a position in Bionano Genomics in Q1 2021 and has held it in 3 quarters since.
Glassman Wealth Services's Bionano Genomics position peaked at $5K in Q2 2021.
143 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2022.

Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.